John D. Zeuli

541 total citations
17 papers, 250 citations indexed

About

John D. Zeuli is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, John D. Zeuli has authored 17 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 7 papers in Virology and 4 papers in Emergency Medicine. Recurrent topics in John D. Zeuli's work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (4 papers). John D. Zeuli is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (4 papers). John D. Zeuli collaborates with scholars based in United States. John D. Zeuli's co-authors include Zelalem Temesgen, Christina G. Rivera, Douglas W. Challener, Kelly M. Pennington, Fnu Shweta, John Wilson, Mary Jo Burgess, Mary J. Kasten, Lynn L. Estes and Stacey A. Rizza and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and AIDS.

In The Last Decade

John D. Zeuli

15 papers receiving 245 citations

Peers

John D. Zeuli

EPIDE

VIROL

Chris Keh United States

Thomas J. Moskal United States

Andrew Scourfield United Kingdom

Emily Blodget United States

Michael Zilly Germany

Maristela Miyamoto Brazil

Angela Sansone‐Parsons United States

Simbarashe Zvada South Africa

Anjana Grandhi United States

Mohammed Janabi Tanzania

Chris Keh United States

John D. Zeuli

81 ×0.5

79 ×0.7

EPIDE

10 ×0.3

34 ×0.8

VIROL

19 ×0.6

Citations per year, relative to John D. Zeuli John D. Zeuli (= 1×) peers Chris Keh

Countries citing papers authored by John D. Zeuli

Since Specialization

Citations

This map shows the geographic impact of John D. Zeuli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Zeuli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Zeuli more than expected).

Fields of papers citing papers by John D. Zeuli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Zeuli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Zeuli. The network helps show where John D. Zeuli may publish in the future.

Co-authorship network of co-authors of John D. Zeuli

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Zeuli. A scholar is included among the top collaborators of John D. Zeuli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Zeuli. John D. Zeuli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Rivera, Christina G., et al.. (2024). Pharmacology of emerging drugs for the treatment of multi-drug resistant tuberculosis. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 37. 100470–100470. 3 indexed citations

Rivera, Christina G., et al.. (2023). HIV Pre-Exposure Prophylaxis: New and Upcoming Drugs to Address the HIV Epidemic. Drugs. 83(18). 1677–1698. 8 indexed citations

Zeuli, John D., Christina G. Rivera, Jessica Wright, et al.. (2023). Pharmacogenomic panel testing provides insight and enhances medication management in people with HIV. AIDS. 37(10). 1525–1533. 2 indexed citations

Zeuli, John D., et al.. (2022). Cabotegravir: a novel HIV integrase inhibitor combined with rilpivirine as the first long-acting injectable program for the treatment of HIV infection. Drugs of today. 58(12). 555–576. 1 indexed citations

Tai, Don Bambino Geno, Maryam Mahmood, Joseph D. Yao, et al.. (2022). False-positive HIV and viral hepatitis serologic test results in a cluster of pork processing plant workers. SHILAP Revista de lepidopterología. 2(3). 100083–100083.

Pennington, Kelly M., Douglas W. Challener, Christina G. Rivera, et al.. (2021). Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 24. 100244–100244. 86 indexed citations

Rivera, Christina G., et al.. (2021). Hepatotoxicity of Contemporary Antiretroviral Drugs: A Review and Evaluation of Published Clinical Data. Cells. 10(5). 1263–1263. 20 indexed citations

Rivera, Christina G., et al.. (2021). Unexpected Vancomycin Pharmacokinetic Profile Secondary to Macromolecular Complexing: A Case Series. Therapeutic Drug Monitoring. 43(5). 696–700.

Rivera, Christina G., et al.. (2021). Hepatotoxicity of contemporary antiretroviral drugs. Current Opinion in HIV and AIDS. 16(6). 279–285. 7 indexed citations

10.

Zeuli, John D., et al.. (2019). Bictegravir, a novel integrase inhibitor for the treatment of HIVinfection. Drugs of today. 55(11). 669–669. 14 indexed citations

11.

Rizza, Stefano, et al.. (2019). Ibalizumab for the treatment of multidrug-resistant HIV-1 infection. Drugs of today. 55(1). 25–25. 17 indexed citations

12.

Smith, Bradley L., Christina G. Rivera, Ross Dierkhising, et al.. (2018). 1243. Comparative Analysis of Antimicrobial-related Adverse Events in the Outpatient Treatment of Staphylococcal Infections. Open Forum Infectious Diseases. 5(suppl_1). S378–S378. 1 indexed citations

13.

Formea, Christine M., Wayne T. Nicholson, Carolyn R. Rohrer Vitek, et al.. (2018). Implementation of a pharmacogenomics education program for pharmacists. American Journal of Health-System Pharmacy. 75(23). 1939–1946. 20 indexed citations

14.

Sampath, Rahul, John D. Zeuli, Stacey A. Rizza, & Zelalem Temesgen. (2016). Tenofovir alafenamide fumarate for the treatment of HIV infection. Drugs of today. 52(11). 617–617. 4 indexed citations

15.

Cummins, Nathan W., Andrew D. Badley, Mary J. Kasten, et al.. (2016). Twenty years of human immunodeficiency virus care at the Mayo Clinic: Past, present and future. World Journal of Virology. 5(2). 63–63. 3 indexed citations

16.

Burgess, Mary Jo, Mary J. Kasten, & John D. Zeuli. (2015). Management of HIV/AIDS in older patients–drug/drug interactions and adherence to antiretroviral therapy. HIV/AIDS - Research and Palliative Care. 7. 251–251. 33 indexed citations

17.

Zeuli, John D., John Wilson, & Lynn L. Estes. (2012). Effect of Combined Fluoroquinolone and Azole Use on QT Prolongation in Hematology Patients. Antimicrobial Agents and Chemotherapy. 57(3). 1121–1127. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact